1 王玉,李晓玫,王海燕. 白介素-1 β通过JNK/p38信号转导通路调控肾系膜细胞表达α-平滑肌肌动蛋白[J]. 生理学报, 2002, 54(3): 244~250.2 王纪文,曲鹏,姜华,等. 抑制NF-κB对Toll样受体4在Goldblatt鼠左室心肌中表达的影响[J]. 高血压杂志, 2005, 18(7): 427~431.3 陈仁金,王珍珍,杨章平,等. 中国荷斯坦牛Toll样受体4基因的遗传多态性与体细胞评分的关联分析[J].中国畜牧兽医, 2013, 40(11): 134~138.4 高庆贞,吕家驹,张辉,等. 阻断MAPK通路对前列腺癌细胞增殖的影响[J]. 山东大学学报(医学版), 2006, 44(5): 501~507.5 Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity[J]. Cell, 2006, 124(4): 783~801.6 Boehkov V N, Kadl A, Huber J, et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage[J].Nature, 2002, 419(6902):77~81.7 Burrough E R, DiVerde K D, Sahin O, et al. Expression of toll-like receptors 2 and 4 in subplacental trophoblasts from guinea pigs(Cavia porcellus) following infection with Campylobacter jejuni[J]. Vet Pathol, 2011, 48(2): 381~2388.8 Clark D A, Chaouat G, Banwatt D, et al. Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA×DBA/2 mouse model: Ⅱ. Fecal LPS levels in colonies with different basal abortion rates[J]. Am J Reprod Immunol, 2008, 60(6): 529~533.9 Deng F, Han F, Wu C. Expression and immune effect of toll-like receptor 4 in human trophoblast cells[J]. Medical Sciences, 2009, 29(3): 359~362.10 Ferwerda B, McCall M B, Verheijen K, et al. Functional consequences of toll-like receptor 4 polymorphisms[J]. Mol Med, 2008, 14(5~6): 346~352.11 Friebe A, Douglas A J, Solano E,et al. Neutralization of LPS or blockage of TLR4 signaling prevents stress-triggered fetal loss in murine pregnancy[J]. Journal of Molecular Medicine, 2011, 89(7): 689~699.12 Gonzalez J M, Xu H, Ofori E, et al. Toll-like receptors in the uterus, cervix, and placenta: Is pregnancy an immunosuppressed state[J]. Am J Obstet Gynecol, 2007, 197(3): 296.13 Haziot A, Ferrero E, Kntgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice[J]. Immunity, 1996, 4(4): 407~414.14 Haziot A, Lin X Y, Zhang F, et al. Cutting edge: The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent[J]. The Journal of Immunology, 1998, 160(6): 2570~2572.15 Ishihara S, Rumi M, Cava C O, et al. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation[J]. Curr Pharm Des, 2006, 12(32):4215~4228.16 Jin M S, Lee J O. Structures of the toll-like receptor family and its ligand complexes[J]. Immunity, 2008, 29(2): 182~191.17 Kubo H, Ishizawa K. Comment on cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury[J]. The Journal of Immunology, 2006, 176(7): 3856~3857.18 Leon C G, Tory R, Jia J, et al. Discovery and development of toll-like receptor 4(TLR4) antagonists: A new paradigm for treating sepsis and other diseases[J]. Pharm Res, 2008, 25(8): 1751~1761.19 Li T, Hu J, Thomas J A, et al. Differential induction of apoptosis by LPS and taxol in monocytic cells[J]. Mol Immunol, 2005, 42(9): 1049~1055.20 Liu H, Redline R W, Han Y W. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response[J]. J Immunol, 2007, 179(4): 2501~2508.21 Ma Y, Krikun G, Abrahams V M, et al. Cell type-specific expression and function of toll-like receptor 2 and 4 in human placenta: Implications in fetal infection[J]. Placenta, 2007, 28(10): 1024~1031.22 Mulla M J, Brosens J J, Chamley L W, et al. Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/ MyD88 pathway[J]. Am J Reprod Immunol, 2009, 62(2): 96~111.23 Newton R, Holden N S, Catley M C, et al. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IκB kinase inhibitors[J]. Pharmacol Exp ther, 2007, 321(2): 734~742.24 Ozoe A, Isobe N, Yoshimura Y. Expression of toll-like receptors(TLRs) and TLR4 response to lipopolysaccharide in hen oviduct[J]. J Elsevier, 2009, 127(3~4):259~268.25 Palsson E M, O’Neill L A. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4[J]. Immunology, 2004, 113(2): 153~162.26 Romagne F. Current and future drugs targeting one class of innate immunity receptors: The toll-like receptors[J]. Drug Discov Today, 2007, 12(1~2): 80~87.27 Riley J K, Nelson D M. Toll-like receptors in pregnancy disorders and placental dysfunction[J]. Clin Rev Allergy Immunol, 2010, 39(3):185~193.28 Sheedy F J, O’Neill L A. The Troll in Toll: Mal and TRAM as bridges for TLR2 and TLR4 signaling[J]. Leukoc Biol, 2007, 82(2): 196~203.29 Sumitomo M, Tachibana M, Ozu C,et al. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated I kappa B alpha overexpression[J].Hum Gene Ther, 1999, 10(1): 37~48.30 Wang H, Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: The role of toll-like receptor 4[J]. Biology of reproduction, 2003, 69(6): 1957~1963.31 Watanabe S, Kumazawa Y, Inoue J. Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14[J]. PLoS One, 2013, 8(4): e60078.32 Yamamoto M, Sato S, Hemmi H,et al. Role of adaptor TRIF in the MyD88-independent toll-like recepotor signaling pathway[J]. Science, 2003, 301(5633): 640~643.33 Yu L, Wang L, Chen S. Dual character of toll-like receptor signaling: Pro-tumorigenic effects and anti-tumor functions[J]. Biochim Biophys Acta, 2013, 1835(2): 144~154.34 Zhang M, Nii T, Isobe N,et al. Expression of toll-like receptors and effects of lipopolysaccharide on the expression of proinflammatory cytokines and chemokine in the testis and epididymis of roosters[J]. Poultry Science, 2012, 91(8):1997~2003. |